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Abstract 
The presence of high concentrations of glutamate in the extracellular fluid following 
brain trauma or ischaemia may contribute substantially to subsequent impairments of 
neuronal function. In this study, glutamate was applied to hippocampal slices for several 
minutes, producing over-depolarisation which was reflected in an initial loss of evoked 
population potential size in the CA1 region. Orthodromic population spikes recovered 
only partially over the following 60 minutes, whereas antidromic spikes and excitatory 
postsynaptic potentials (epsps) showed greater recovery, implying a change in epsp – 
spike coupling (E-S coupling) which was confirmed by intracellular recording from CA1 
pyramidal cells. The recovery of epsps was enhanced further by dizocilpine suggesting 
that the long-lasting glutamate-induced change in E-S coupling involves NMDA 
receptors. This was supported by experiments showing that when isolated NMDA-
receptor mediated epsps were studied in isolation, there was only partial recovery 
following glutamate, unlike the composite epsps. The recovery of orthodromic 
population spikes and NMDA receptor-mediated epsps following glutamate was 
enhanced by the adenosine A1 receptor blocker DPCPX, the A2A receptor antagonist 
SCH58261, or adenosine deaminase, associated with a loss of restoration to normal of 
the glutamate-induced E-S depression. The results indicate that the long-lasting 
depression of neuronal excitability following recovery from glutamate is associated with 
a depression of E-S coupling, This effect is partly dependent on activation of NMDA 
receptors which modify adenosine release or the sensitivity of adenosine receptors. The 
results may have implications for the use of A1 and A2A receptor ligands as cognitive 
enhancers or neuroprotectants. 
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Introduction 
     It is well established that the activation of adenosine A1 or A2A receptors has major 
influences on neuronal activity including the ability to modulate plastic phenomena such 
as long-term potentiation (LTP) and long-term depression (LTD) (Costenla et al., 1999; 
de Mendonca & Ribeiro, 2001; Fontinha et al., 2009; Kukley et al. 2005; Moore et al. 
2003)  In addition, both A1 and A2A receptors are known to influence neuronal recovery 
following injurious stimuli or events such as ischaemia or CNS trauma (von Lubitz et al., 
1996; Jones et al., 1998; Kitagawa et al., 2002; Pugliese et al., 2003; Stone et al., 
2009), the subsequent neurodegeneration in these cases being considered attributable 
to locally elevated concentrations of glutamate or a related agonist such as quinolinic 
acid (Benveniste et al., 1984; Baratte et al., 1998; Nishizawa, 2001; Szatkowski and 
Attwell, 1994; Stone, 2001). Many attempts have been made to devise 
electrophysiological techniques in acute slice preparations which might represent an 
appropriate model for such events (Schurr et al., 2001; Latini et al., 1999a,b; Pugliese et 
al. 2003), facilitating an understanding of their electrophysiological and molecular basis.  
     Here we describe the effects on synaptic transmission of a relatively intense 
exposure to glutamate (5mM applied for 10min) which generates a depression of 
evoked field potentials lasting at least 60 min. We have examined the associated 
electrophysiological changes in this situation and then assessed the effects of A1 and 
A2A receptor blockade on those changes. The results suggest that the procedures used 
might form the basis for further investigation into the basis of interactions between 
glutamate and adenosine receptor function in relation to long-term changes of neuronal 
function.  In particular, the results suggest that adenosine receptors are able to 
modulate long-lasting alterations of synaptic transmission and neuronal excitability 
caused by glutamate, supporting the view that adenosine receptors have therapeutic 
potential as targets for preventing glutamate-induced dysfunction. 
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Methods 
Ethical information    
   All procedures performed in this work were in accordance with the regulations and 
recommendations of the Animals (Scientific Procedures) Act, 1986 of the United 
Kingdom Home Office. 
   Hippocampal slices were prepared as described previously (Ferguson and Stone, 
2008). Briefly, male Wistar rats (100-150g) were killed by an overdose of urethane 
(1ml/100g body weight, administered i.p. as a 25% solution) and cervical dislocation. 
The brain was removed into ice-cold artificial cerebrospinal fluid (aCSF) of composition: 
(in mM) NaCl 115; KH2PO4  2.2; KCl  2; MgSO4  1.2; NaHCO3 25; CaCl2 2.5; glucose 
10, gassed with 5%CO2 in oxygen. The hippocampi were removed and sliced into 
450μm transverse slices using a McIlwain tissue chopper. Slices were selected from 
approximately the middle one third of each hippocampus, a restriction which provided 
approximately 6 slices from each. The slices were preincubated at room temperature for 
at least 1 hour in a water-saturated atmosphere of 5%CO2 in O2 before individual slices 
were transferred to a 1 ml capacity superfusion chamber for recording. For extracellular 
recording, slices were superfused at 28-30°C with aCSF at a flow rate of 3-4 ml/min. A 
concentric bipolar electrode (Harvard Apparatus, Edenbridge, UK) was used for 
stimulation in stratum radiatum, using stimuli delivered at 0.1 Hz with a pulse width of 
50-300μs. The stimulating electrode tip was located immediately internal to the stratum 
pyramidale at the border between the CA1 and CA2 regions. For antidromically-evoked 
potentials, the stimulating electrode was placed in contact with the alvear white matter 
containing the axons of the pyramidal neurons. Recording electrodes were constructed 
from fibre-containing borosilicate glass capillary tubing (Harvard Apparatus, Edenbridge, 
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Kent, UK), with the tips broken back to 2-4μM, DC resistance approximately 5MΩ. 
Electrodes were filled with a solution of 1M NaCl. The recording electrode tip was 
placed either in the stratum pyramidale (for population spike recordings) or internal to 
the CA1 pyramidal cell layer at the point of maximum epsp amplitude. The signal was 
amplified and captured on a micro1401 interface (CED, Cambridge Electronic Design, 
Cambridge, UK) for storage on computer and subsequent analysis. 
   Intracellular recordings were made as described previously (Stone, 2007), using sharp 
electrodes pulled from borosilicate fibre-containing glass tubing (Clark Electromedical, 
Reading, UK, and Harvard Apparatus, Edenbridge, UK) using a vertical Narashige 
puller. The electrodes were filled with 1M potassium acetate, and had tip resistances of 
90-120 MΩ. Potentials were amplified via an Axoclamp-2 system (Axon Instruments, 
Molecular Devices, New Orleans, USA)) or a Neurolog NL102 DC amplifier (Digitimer 
Ltd., Welwyn Garden City, UK) in bridge balance mode, with a filter bandwidth between 
DC and 500Hz to reduce higher frequency components of epsp recordings. A 
modification of the amplifier allowed 1-10 ms periods of increased capacitance 
compensation (buzz) to be applied remotely to facilitate penetration. Following 
penetration, cells were allowed to reach a maximum resting potential and then left for 30 
minutes before the addition of compounds. Cells were only used if they exhibited stable 
resting potentials of at least –60mV. Neuronal excitability was tested by applying 
intracellular depolarising current pulses between 0.05 and 1.0nA amplitude for 300, 500 
or 800ms. Input resistance was monitored using 0.05 to 1.0nA hyperpolarizing pulses 
lasting 300 or 500ms. Responses were digitised at 20kHz via a CED (Cambridge 
Electronic Design, Cambridge, UK) micro1401 interface and stored on computer for 
later analysis using the Signal programme. Stable cells were maintained for between 1 
and 6 hours after penetration. Only one cell was studied in each slice, to preclude the 
possibility that drug superfusion might alter the responsiveness of subsequent neurons 
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in the same slice. Stimulation and recording electrode locations were as for the 
extracellular recordings noted above.  
 
Sources 
   L-glutamate, N-methyl-D-aspartate (NMDA), adenosine and adenosine deaminase 
(type VII) were obtained from Sigma-Aldrich Chemicals (Poole, Dorset, UK), while 
dizocilpine, 6,7 – dinitroquinoxaline-2,3-dione (DNQX),1,3-dipropyl-8-
cyclopentylxanthine (DPCPX) and 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3e]-
1,2,4-triazolo[1,5-c]-pyrimidine (SCH58261) were obtained from Tocris Bioscience 
(Bristol, UK).  
 
Measurements and statistics 
   The amplitude of population spikes was taken as the potential difference between the 
negative and positive peak. The negative slope of the epsp was taken as the gradient of 
the line of best fit of all sampled points between approximately 25% and 75% after the 
start of the negative slope. The epsp amplitude was taken as the potential difference 
between the negative peak and the return to baseline. 
   Data are presented as mean ± standard error. Baseline values were obtained from a 
stable 10min period of evoked potential size prior to the addition of any drugs, and 
which was then taken as 100%. Linear and non-linear regression analyses were 
performed using GraphPad Instat and Prism software.  
   For statistical comparisons between groups, unpaired two-tailed t-tests were used 
except where two or more data sets were compared with a common control, in which 
case a one-way analysis of variance (ANOVA) was normally performed, followed by 
Dunnett’s multiple comparisons test or Bonferroni’s multiple comparison test when 
sample groups were of different sizes. 
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Results 
Glutamate and orthodromic population spikes 
   In preliminary investigations, glutamate was applied at various concentrations to 
assess the effects upon the orthodromic population spikes evoked from CA1 neurons. 
While micromolar concentrations could induce a partial and fully reversible loss of 
response size, higher millimolar concentrations produced a complete loss of the 
potential with only partial recovery. A concentration of 5mM was selected for routine use 
as it produced an initial over-depolarisation leading to a complete loss of response 
which persisted for 10-20min following glutamate perfusion. The response then partially 
recovered until it reached a stable plateau. A higher concentration of 10mM produced 
similar effects but with a slower time course and a poorer and more variable plateau 
recovery (Fig. 1Aa, b). 
 
Antidromic population spikes 
   In contrast, when applications of 5mM glutamate were examined on antidromically-
evoked population spikes, the potentials were seen to decrease only partially in 
response to 5mM glutamate, but were never suppressed completely. Another distinction 
from orthodromic spikes was that, on removing the glutamate, antidromic spikes 
recovered to a level which was not significantly different from the initial baseline (90.3% 
± 8.5, n = 4, P = 0.34, one sample t-test) and with no long-lasting decrease in potential 
size (Fig. 1Ba,b).  
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Composite field epsps 
   As in the case of orthodromic population spikes, 5mM glutamate perfusion for 10min 
resulted in a complete loss of the field epsps. This again persisted for approximately 10-
20min after glutamate was removed. The epsps then recovered but, unlike orthodromic 
spikes, they recovered to the initial pre-glutamate levels and did not normally show 
pronounced long-lasting changes in slope or amplitude compared with pre-glutamate 
treatment (Fig. 1Ca,b). Taken together with the partial reversibility of population spikes, 
these results suggest a reduction of epsp-spike coupling (E-S coupling). 
 
NMDA receptor involvement  
      The use-dependent NMDA channel blocker, dizocilpine (10µM) was perfused prior 
to, during and after 5mM glutamate exposure. The overdepolarisation produced by 
glutamate still decreased the epsp size to zero for approximately 10-20min post-
glutamate, as in the experiments described above (Fig. 2Aa,b). However, in slices 
superfused with dizocilpine, post-glutamate recovery significantly exceeded not only the 
post-glutamate recoveries of control responses without the antagonist but also 
exceeded even the initial baseline size with respect to both epsp slope and amplitude 
(for slope, P = 0.011 relative to treatment with glutamate alone, P =  0.004 relative to 
baseline; for amplitude, P  =  0.0003 relative to treatment with glutamate alone; P  =  
0.002 relative to baseline).  
   A five minute perfusion of 25µM NMDA produced an initial loss of the orthodromic 
population spike. After a washout period of several minutes it was observed that, as 
with glutamate superfusion, the population spike returned to a plateau level that was 
lower than the pre-NMDA control potential size (Fig. 2Ba,b).  
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Isolated NMDA receptor-mediated epsps 
   In order to probe further the involvement of NMDA receptors in the long-lasting effects 
of glutamate, NMDA receptor-mediated epsps were isolated by superfusing slices with 
magnesium-free aCSF containing 20µM DNQX. Superfusion with glutamate at 5mM 
then induced a change in epsp slope and amplitude similar to that observed in the 
examination of composite epsps, with a period of overdepolarisation and complete loss 
of the epsp but followed by only a partial recovery to around 50% of the baseline (Fig. 
2Ca,b).  
    From these results, it was hypothesized that the use of 5mM glutamate may induce 
an NMDA receptor-mediated dissociation between the field epsp and the orthodromic 
population spike which could be further investigated with E-S coupling experiments. 
 
Intracellular experiments. 
   To obtain precise information on the E-S coupling in the CA1 region, individual 
neurons were examined using intracellular recordings rather than the more traditional, 
but cruder, analysis of population field potentials. The intracellular correlate of 
extracellular E-S coupling is the probability of action potential initiation in individual cells 
in response to constant epsp inputs, this probability in turn being associated with 
changes in firing threshold (Andersen et al., 1980; Pugliese et al., 1994; Jester et al., 
1995). A total of 11 neurons were examined in which the probability of epsp-induced 
spike initiation was measured under control conditions and 50min after the superfusion 
of the slice with glutamate. The number of successful epsp-induced spikes was 
recorded at 5μA stimulus intervals and these were plotted to allow interpolation of the 
stimulus current able to generate a theoretical spike success of 50%.  Responses from 
a typical neuron are illustrated in Fig. 3A, together with a summary graph which shows 
the mean ± s.e.m. spike failure rates at different stimulus intensities in the control period 
 9
and during recovery 50min after glutamate superfusion (Fig. 3B). From plots of the 
stimulus – probability relationship for individual neurons, the stimulus strength required 
to elicit a failure rate of 50% spike initiation was increased from 76.1 μA ± 1.64, to 80.5 
μA ± 1.44 (n = 11, P = 0.019, paired t test) (Fig. 3B). In addition, the membrane 
potential threshold for the action potential, measured as the point of discontinuity 
between the epsp and the spike potential, was increased by an average of 2.48 mV ± 
0.25 (n = 11, P < 0.001; one-sample t test).  
 
 
Adenosine A1 receptors 
   Since adenosine is known to be present in the extracellular space of tissue slices and 
its release can be increased by the activation of glutamate receptors (Manzoni et al., 
1994; Hoehn & White, 1990), it was hypothesised that it could contribute to the long-
lasting effects of glutamate on the evoked potentials. The adenosine antagonist 
DPCPX, at an A1-receptor-selective concentration of 30nM, was perfused for 10min 
prior to and during the application of 5mM glutamate. The blockade of A1 receptors did 
not produce any change in the immediate response to glutamate, but it did result in a 
significant improvement in recovery of the orthodromic  population spike amplitude 
compared with controls, with a larger potential size recorded at the 60min recovery 
plateau following glutamate with DPCPX (n = 11) compared with glutamate alone 
(64.5% ± 3.1; n = 9; P = 0.01)(Fig. 4A,B). DMSO, the solvent used to dissolve DPCPX 
was tested at its final superfusion concentration of 0.05%, as it is a free radical 
scavenger known to alter electrophysiological responses in hippocampal slices 
(Hülsmann et al., 1999; Greiner et al., 2000). However, DMSO did not significantly 
affect the post-glutamate recovery of orthodromic population spikes (76.0% ± 8.9, n = 5) 
compared to those treated with glutamate alone. 
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      The same experimental protocol was then tested using antidromic population spikes 
and field epsps. When 30nM DPCPX was perfused 10min prior to and during 5mM 
glutamate, there was no difference in the observed changes in antidromic spike 
amplitude (Fig. 4C) or composite field epsps (Fig. 4D). As the recovery for the 
orthodromic field epsps may have been influenced by differences in the epsp response 
sizes between groups (see section on relationships below), t-tests were performed 
which revealed no significant differences in this parameter (epsp slope: glutamate: -0.56 
± 0.15mV/ms, glutamate + DPCPX: -0.92 ± 0.29mV/ms, P = 0.25; epsp amplitude: 
glutamate 1.3 ± 1.0mV, glutamate + DPCPX: 1.8 ±  0.5mV,  P = 0.25).  
   Since the effect of A1 receptor blockade upon the response to glutamate of 
orthodromic population spikes was not observed using antidromic population spikes or 
field epsps, the results imply that A1 receptor blockade prevents the NMDA receptor-
induced depression of E-S coupling. Therefore, the experiments were repeated using 
NMDA receptor-mediated epsps isolated by superfusing the slices with DNQX in 
nominally magnesium-free aCSF. DPCPX was perfused for 10min prior to and during 
5mM glutamate as before. Control responses that were over 0.8mV in amplitude were 
selected to match the range of orthodromic composite epsp sizes used above. It was 
noted that DPCPX significantly enhanced the recovery from glutamate of NMDA 
receptor-mediated epsps (82.0% ± 7.7, n = 6) compared with the use of glutamate 
alone (53.3% ± 9.7, n = 7;  P = 0.045, unpaired t test), supporting the possibility that the 
effects of A1 receptor blockade upon the response to glutamate of orthodromic spikes 
may involve the modulation of NMDA receptors (Fig. 4E,F). 
   Intracellular measurements of neuronal firing probability, as outlined above, were 
made in slices subjected to the DPCPX and glutamate perfusion protocol. A total of 8 
neurons were tested, in which the stimulus strength required to elicit a failure rate of 
50% spike initiation was unchanged between baseline conditions and measurements 
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made 50 min after DPCPX and glutamate perfusion (baseline 74.33 μA ± 1.5; after 
glutamate and DPCPX 75.45 μA ± 1.48 (P = 0.16, n = 8, paired t test) (Fig. 5). The 
difference in action potential thresholds between the control and test conditions was 
0.72 mV ± 0.45, which was also not statistically significantly different (P = 0.15, one-
sample t test, n = 8), indicating that DPCPX prevented the alterations of E-S coupling 
produced by glutamate application. 
 
Adenosine A2A receptors 
     Since the effects of DPCPX pointed to a role for endogenous adenosine in the 
degree of recovery after glutamate, it was felt appropriate to assess whether there might 
also be any influence on recovery of A2A receptor activation, especially since A2A 
receptors are known to facilitate glutamate release and could therefore increase the 
degree of glutamate receptor activation.  The A2A receptor antagonist, SCH 58261 
(1µM), was used in a similar manner to DPCPX. SCH 58261 was perfused prior to, 
during and after 5mM glutamate during the recording of orthodromic population spikes. 
Following perfusion with SCH58261, there was a significantly greater recovery of 
orthodromic spike amplitude after the glutamate application, with the potentials 
recovering to 101.7% ± 8.5  of the initial baseline after SCH58261 (n = 9) compared 
with recovery to only 71.7% ± 9.3 of the baseline in slices not treated with SCH58261 (n 
= 7, P = 0.033, unpaired t  test). Interestingly, it was also observed that perfusion of 
SCH 58261 alone for 60 min resulted in a significant depression of the orthodromic 
population spike amplitude (85.0% ± 2.2; n = 5; P = 0.003 one sample t test). 
 
 
 
Adenosine deaminase 
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     The use of antagonist compounds is inevitably complicated by questions of 
selectivity, especially when differences between pre- and post-synaptic receptors for the 
same agonist are under discussion. Therefore, it was decided to repeat the same 
experimental protocol as above but using adenosine deaminase to metabolise 
endogenous adenosine and thus remove its activation of receptors.  Adenosine 
deaminase (ADA, 0.2U/ml) was superfused from 10 minutes prior to glutamate 
application until 60 minutes after ending the application. There was no change in the 
size of the population spikes during perfusion with ADA in the control period (mean 
potential size at baseline 100.25% ± 1.73; size in ADA 100.5% ± 1.78,  n = 8, n.s.). 
However, there was a significantly greater degree of recovery following the glutamate, 
control slices recovering to 68.4% ± 4.07 of the baseline potential size, while those 
treated with ADA showed recovery to 80.1% ± 3.33 of  baseline (n = 8, P = 0.042). 
 
Relationships between neuronal recovery and initial response size 
     During the course of this work, a number of observations were made which indicated 
a relationship between the initial evoked potential size and the degree of recovery 
observed following glutamate. These relationships suggest a differential role of NMDA 
and non-NMDA receptor-mediated components in the recovery which would be entirely 
consistent with the main body of results reported here but which, to our knowledge, 
have not been reported before.  
     The extent of post-glutamate recovery of the orthodromic population spike was 
dependent on the initial spike amplitude. Smaller initial spikes were associated with a 
lesser recovery after glutamate applications. This was supported by scatter plots of the 
post-glutamate recovery against the initial population spike size, which revealed 
significant positive correlations between these parameters using both 5mM and 10mM 
glutamate (Fig. 1A,c). In subsequent experiments, the average size of population spike 
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amplitudes between treatment groups were compared to ensure that the outcomes 
were not influenced by this covariate (see section on Adenosine A1 Receptors, above). 
In contrast, there was no correlation between initial antidromic spike size and 
percentage recovery following glutamate (n = 4). 
     Recovery of epsps in different slices could occur to less than, or more than, the initial 
potential size. This was reflected in scatter-plots of epsp slope or amplitude and 
percentage recovery of either parameter which suggested that smaller initial epsps 
generally recovered to a greater extent than larger epsps. This relationship was 
opposite to that seen for the population spikes and was non-linear. The data were fitted 
to a one phase exponential decay curve (slope R2 = 0.74, amplitude R2 = 0.57) (Fig. 
1Cc,d). 
 
NMDA receptors 
     Davies & Collingridge (1989) have previously reported that smaller epsp amplitudes 
were associated with a smaller NMDA receptor-mediated contribution: small epsps were 
insensitive to NMDA receptor antagonists until stimulation was increased sufficiently to 
obtain a slowly-emerging NMDA receptor component. Since, in the present work, 
smaller epsps showed a tendency to recover better than large epsps following 
glutamate treatment, it was hypothesized that this might be due to a smaller NMDA 
receptor-mediated component of the smaller epsp. The effects of glutamate upon field 
epsps were therefore studied further by testing the effects of glutamate in the presence 
of dizocilpine, and by examining isolated NMDA receptor-mediated epsps. 
     Scatter-plots were created of the range of initial epsp size versus the percentage 
recoveries of epsp slope and epsp amplitude following glutamate perfusion. In those 
experiments involving dizocilpine and glutamate, the recovery of field epsp amplitude 
depended significantly upon the initial epsp slope and amplitude (R2 = 0.83, P < 0.001) 
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whereas no such significant relationship existed in the absence of dizocilpine. These 
results suggested that it is the non-NMDA sensitive component of the epsp which 
determines the degree of recovery following glutamate. The extent of recovery of 
population spikes after slice superfusion with NMDA was also affected by the initial 
spike amplitude, as it had been after glutamate application. However, in contrast to the 
effect of glutamate, a contrary, negative relationship was obtained, in which smaller 
initial population spikes were significantly correlated with greater post-NMDA recoveries 
whilst larger potentials had smaller recoveries (Fig. 2B, c). 
 
 
 
Discussion 
   The effects of glutamate observed here are broadly consistent with those reported in 
the literature with a complete loss of evoked responses upon application of millimolar 
concentrations of glutamate for several minutes followed by return to a reduced 
potential size during washout (Wallis et al., 1994; Alici et al., 1996). Others have noted a 
varying degree and time course of recovery, depending on factors such as calcium 
levels (Alici et al. 1996; Limbrick et al., 2003). Coulter et al. (1992) and Limbrick et al. 
(2003) have observed what is probably a related phenomenon, of prolonged changes in 
membrane potential in hippocampal neuronal cultures using 500µM glutamate in the 
presence of 10µM glycine, which they termed “extended neuronal depolarization”. 
     The facts that orthodromic spikes behave in a manner opposite to antidromic spikes 
and epsps, and that, overall, the latter potentials recover to a much greater extent than 
orthodromic spikes, suggest that a major determinant of recovery lies in events at the 
level of the synapse. The most likely event would be an action of glutamate receptors 
on E-S coupling. This possibility has been confirmed by our intracellular recordings 
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which show that the post-glutamate recovery period is associated with a significant 
decrease in neuronal firing probability, often (but not always) associated with an 
increased action potential threshold in response to synaptic stimulation. Indeed, 
decreased E-S coupling has previously been described after electrical stimulation 
leading to LTD (Daoudal et al., 2002), consistent with the possibility that common 
mechanisms underlie both electrical LTD and the long-lasting depression described 
here. The converse relationship, with enhanced E-S coupling after high-frequency 
stimulation or tetra-ethylammonium, has also been described (Bernard and Wheal, 
1995; Bernard et al., 1998; Taube and Schwartzkroin, 1988). 
     Whereas long-term potentiation (LTP) is known to involve a degree of epsp-spike (E-
S) potentiation, the role of E-S coupling in LTD, has received less experimental 
attention. Increased E-S potentiation implies an increased efficiency of transmission 
resulting in larger population spikes being evoked by a constant epsp amplitude 
(Andersen et al., 1980; Jester et al. 1995). There are a few studies describing 
stimulation-induced or high K+-induced E-S depression but few have considered the 
effects of glutamate itself. 
 
 
Adenosine 
   The possible role of adenosine receptors in the phenomena described here was 
examined as it is known that adenosine is released at high concentrations during 
ischaemia (Latini et al., 1999b) and is a known preconditioning agent (Liu et al., 1991; 
Heurteaux et al., 1995; Perez-Pinzon et al., 1996; Kitagawa et al., 2002; Ferguson & 
Stone 2008). It was found that blockade of adenosine A1 receptors increased post-
glutamate recovery, an observation that would be consistent with previous evidence that 
glutamate or NMDA can induce adenosine release (Hoehn & White, 1990; Pedata et al., 
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1991; Manzoni et al., 1994). There is ample evidence from several groups studying 
evoked potential size or the levels of adenosine present in the bathing medium that 
adenosine release from slices in response to glutamate or other depolarising stimuli can 
reach concentrations sufficient to inhibit spike potential size or recovery (Manzoni et al., 
1994; Brunedge and Dunwiddie, 1996; Cunha et al., 1996; 1998; Sebastiao et al., 2001; 
Frenguelli et al., 2003, 2007; Wall and Dale, 2008)  
     However, adenosine release could not account on its own for the relatively poor 
recovery of orthodromic spikes compared with the full recovery of antidromic spikes and 
epsps. In addition, the adenosine release induced by glutamate or NMDA has been 
shown to be relatively brief : release was normalised within minutes of the washout 
period, with no lasting increase which might readily account for the present results 
(Hoehn & White, 1990; Manzoni et al., 1994). The fact that adenosine deaminase 
improved recovery in a similar fashion to DPCPX supports the view that the presence of 
adenosine – at some stage in the experiment – is largely responsible for the 
phenomena described here, but there must be an additional mechanism to account for 
the different responses of population spikes and epsps.                
     One such possibility to account for the delayed modulatory effects on recovery is that 
a change occurs in the number, distribution or sensitivity of adenosine receptors in 
response to high concentrations of glutamate, especially involving receptors at synaptic 
regions where, as noted above, the results would be consistent with a change of E-S 
coupling (O’Kane & Stone, 1998, 2004). In particular, the results imply that there may 
be an increased sensitivity of postsynaptic adenosine receptors associated with E-S 
coupling, but not presynaptic adenosine receptors regulating transmitter release and 
epsp generation. This is a particularly important distinction to make since the 
presynaptic A1 receptors have been regarded as high affinity sites (Vizi, 2000) which 
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could conceivably respond to very low residual concentrations of adenosine persisting 
beyond the usual detection limits.   
   The present work does not provide any information on the origin of the adenosine 
released by glutamate, whether as a direct result of cellular depolarisation or caused by 
the increased cellular metabolism which is induced by prolonged depolarisation. 
Certainly under conditions such as ischaemia, in which endogenous glutamate release 
is thought to play a significant role in the subsequent cell dysfunction, adenosine 
release can arise either from neurones or from astrocytes. The latter can release large 
quantities of adenosine directly or indirectly (from the metabolism of ATP) under such 
conditions (Sperlagh and Vizi, 1996; Cunha, 2008),   
 
   The efficacy of DPCPX  may involve interactions between A1 receptors and NMDA 
receptors in the hippocampus (de Mendonça & Ribeiro, 1993; Schubert and Kreutzberg, 
1993; Canhão et al., 1994; de Mendonça et al., 1995; Klishin et al., 1995; Nikbakht & 
Stone 2001). The effects of glutamate and A1 receptor blockade were therefore 
examined on NMDA receptor-mediated epsps. When DPCPX was applied in the 
presence of glutamate during the recordings of pharmacologically isolated NMDA 
receptor-mediated epsps, post-glutamate recovery was increased. Previous work on 
NMDA receptor currents in the hippocampus has shown that A1 receptor antagonism 
enhances responses to NMDA receptors. In particular, DPCPX both facilitates the 
NMDA receptor-mediated component of epsps in the rat hippocampal slice (Canhão et 
al., 1994) and 8-cyclopentyl-theophylline (8-CPT) increases the NMDA receptor 
component of hippocampal synaptic currents in hippocampal neurons (Klishin et al., 
1995). Conversely the agonist, 2-chloroadenosine, suppresses NMDA receptor-
mediated epsps in slices (de Mendonça & Ribeiro, 1993) and NMDA-induced currents 
in isolated hippocampal neurons (de Mendonça et al., 1995). Thus, the increase in post-
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glutamate recovery of orthodromic population spikes and NMDA receptor-mediated 
epsps when DPCPX is present may be due to its removal of A1 receptor inhibition of 
NMDA receptors.  
     The A1 adenosine receptors do not seem to be involved in the glutamate-induced 
depression of antidromic potentials, since DPCPX did not prevent the effect. Since it 
has recently been noted that agonists at group I metabotropic glutamate receptors are 
able to produce a prominent depression of antidromic spikes (Clement et al., 2009), an 
effect that might be related to the ability of those agonists to inhibit sodium currents in 
CA1 pyramidal neurons (Carlier et al., 2006), it is possible that a similar effect is 
responsible for the depression seen here. 
   The A2A adenosine receptors enjoy a rather paradoxical pharmacology. Their 
activation tends to facilitate activity in neuronal networks, by a combination of pre- and 
post-synaptic actions on excitability and transmitter release (Ribeiro, 1999; Lopes et al., 
2002), reflected in the enhancement of hippocampal epsps (Cunha et al., 1994) and 
population spikes (Sebastião & Ribeiro, 1992) observed upon exposure to 2-[4-(2-
carboxyethyl)-phenylethylamino]-5’N-ethyl-carboxamido-adenosine (CGS21680), an A2A 
receptor agonist. This activity probably accounts for the significant depression induced 
by SCH 58261 alone. 
   However, activation of A2A receptors can inhibit NMDA receptor-mediated 
depolarisation (Wirkner et al., 2000, 2004) and can regulate synaptic plasticity 
differentially on population spikes and epsps. The induction of LTP and depotentiation 
of epsps are increased and decreased respectively when A2 receptors are activated, 
whereas these forms of plasticity in population spikes are unaffected by A2 receptors 
(Sekino et al., 1991; Fujii et al., 1992, 1999; Forghani & Krnjević, 1995). Antagonists at 
A2A receptors are also neuroprotective, reducing cell death in response to a range of 
insults including glutamate, NMDA, quinolinic acid, oxidative stressors and the selective 
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dopaminergic toxin MPP+ (Lau & Mouradian, 1993; Jones et al., 1998; Connick & 
Stone, 1989, Behan & Stone, 2002; von Lubitz et al., 1996). Indeed, both agonists and 
antagonists seem able to protect neurones (Macgregor & Stone, 1994; Jones et al., 
1998; see Stone et al., 2009).  
 
Response sizes and post-glutamate/NMDA recovery 
     The relationship between initial potential size and recovery appears to be a novel 
observation, although a fuller explanation of the phenomenon will require a separate 
study to explore changes of pre-synaptic and post-synaptic function, the relative 
contributions of different glutamate receptors subtypes, and the roles of the major 
voltage-dependent ion channels. 
    
A positive correlation was discovered between the initial amplitude of orthodromic 
population spikes and the degree of post-glutamate recovery. A similar correlation 
between resting membrane potential and total voltage change has been noted for 
compounds such as cyanide (Englund et al., 2001). This mitochondrial poison tended to 
return membrane potential to a fixed point, so that the induced voltage change 
depended on the initial resting potential. However, such a simple relationship is not 
likely to apply to the present results since no correlation was found for antidromic spike 
size and subsequent recovery, implying that the correlation of orthodromic potentials 
and recovery involves a change in synaptic transmission. 
   On the other hand, field epsps showed a negative trend with respect to post-
glutamate recovery. There was also a negative correlation between orthodromic 
population spike amplitude and post-NMDA recovery: small initial spike amplitudes 
produced larger post-NMDA recoveries whilst larger starting potentials did not recover 
well. An explanation of these observations may lie in the proposal that smaller epsp 
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amplitudes were often associated with a smaller NMDA receptor-mediated component 
compared with larger epsps (Davies & Collingridge, 1989). Thus, in view of the key role 
of NMDA receptors in neuronal function, especially in relation to calcium influx, synaptic 
plasticity and toxicity, it is possible that recovery from glutamate applications depends 
largely on the extent to which activation of NMDA receptors is involved. This conclusion 
is supported by two further results. Firstly the application of dizocilpine, to block NMDA 
receptors during perfusion with glutamate, induced a greater recovery of epsp 
responses. Secondly, isolated NMDA receptor-mediated epsps showed a negative 
trend between epsp size and post-glutamate recovery, as did the normal composite 
epsps. 
   It is possible that the size of the NMDA receptor component of an evoked potential will 
have a major influence on the overall behaviour of that potential in the presence of high 
concentrations of glutamate, and its recovery. For example, it has been shown that a 
form of inhibitory interaction exists between NMDA receptors and AMPA receptors at 
CA1 dendrites (Bazhenov & Kleshchevnikov, 1999) whereby antagonism of one 
receptor-mediated component of the epsp will induce a potentiation of the other. These 
studies are consistent with NMDA receptor stimulation causing a depression of the 
AMPA receptor component of the epsp, and with the effects of dizocilpine  in 
potentiating the post-glutamate recovery of epsps. This explanation of our results is 
supported by previous studies of epsp composition. The NMDA receptor is known to 
increase the linearity of spatial summation of epsps (Cash & Yuste, 1999), which may 
be relevant to the fact that the relationships we have observed with NMDA receptor-
mediated epsps were more clearly seen in relation to amplitude than slope. In addition, 
since the NMDA component of composite epsps arises after the AMPA / kainate 
component (as channel blockade by magnesium is relieved), NMDA receptor blockade 
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induces a decrease in amplitude but not the initial, AMPA/kainate-mediated negative 
slope of epsps in the hippocampal slice (Dahl & Sarvey, 1990). 
   Overall, therefore, the presence of a high concentration of glutamate for 10 minutes is 
sufficient to induce long-lasting changes of E-S coupling, but those changes depend on 
the initial size of the recorded potentials. The degree of recovery can be increased by 
apparent adenosine A1 or A2A receptor blockade, further justifying the possible value of 
such compounds in the prophylaxis or treatment of cerebral ischaemia and trauma. The 
protocol employed here may be a useful in vitro model of long-term impaired neuronal 
function which follows exposure to elevated or pathological concentrations of glutamate 
or agonists such as quinolinic acid.  
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Figure 1  
The effects of glutamate on CA1 evoked responses 
A) a Time course graph showing the average changes in orthodromic population spike 
amplitude in response to 5mM (n = 3) or 10mM (n = 3) glutamate   
b Sample traces of orthodromic population spikes taken from the time points as 
indicated in a.  
Calibrations: 2mV, 5ms  
c Scatterplot showing the relationship between % recovery of the population spike 
following treatment with 5mM or 10mM glutamate and the initial orthodromic spike size. 
Recovery is taken as the average % spike size of a stable 10min plateau period 
following glutamate treatment. There is a significant difference in recovery following 
applications of glutamate at 5mM and 10mM (P<0.0001, ANCOVA).  
B) a Time course graph showing the percentage changes in antidromic population spike 
amplitude produced by superfusion with 5mM glutamate.  The population spikes show a 
recovery following glutamate that does not differ significantly from the baseline (n = 4)  
b Sample waveforms showing an antidromic population spike before, during and after 
perfusion of 5mM glutamate. Calibrations: 2mV, 5ms. 
C) a Time course graphs showing the percentage changes in slope and amplitude for 
field epsps before, during and after superfusion with 5mM glutamate (n = 12). The 
arrows indicate time points from which the sample waveforms in b are taken     
b Sample waveforms of a single field epsp taken from the time points indicated in a. 
Calibrations: 2mV, 5ms. c,d Scatterplots showing the relationship between epsp 
amplitude c or slope d and the % response recovery after glutamate perfusion. 
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Figure 2 
The role of NMDA receptors in mediating responses to glutamate 
A) Time course graphs showing the average changes in field epsp slope and amplitude 
in response to 5mM glutamate alone or in the presence of 10µM dizocilpine. a The 
presence of dizocilpine significantly increases the recovery of the epsp slope following 
glutamate perfusion compared with the initial pre-glutamate baseline (n = 9, P = 0.0044, 
one-sample t-test) and also compared to controls treated with glutamate alone (n = 13, 
P = 0.011, unpaired t- test).  b The presence of dizocilpine significantly increases the 
recovery of the epsp amplitude following glutamate perfusion compared with the initial 
pre-glutamate baseline (n = 9; P = 0.0018, one-sample t test), and also compared to 
controls treated with glutamate alone (n = 13, P = 0.0003, unpaired t test). 
B) a Time course graph showing the average percentage changes in amplitude of 
orthodromic population spikes before, during and after perfusion of 25µM NMDA. The 
arrows indicate the time points from which the sample waveforms in b are taken. 
b Sample waveforms showing an orthodromic population spike before and after 
perfusion of 25µM NMDA. Calibrations: 2mV, 5ms. 
c Scatterplot showing the inverse relationship between orthodromic spike size and % 
recovery of spike size following treatment with 25µM NMDA for 5min. There is a 
significant linear relationship (R2 = 0.69, P = 0.0005).   
C) a Time course graph showing the percentage changes in epsp amplitudes of the 
isolated NMDA receptor-mediated component (obtained in perfusion medium containing 
no magnesium and 20μM DNQX) before, during and after 5mM glutamate perfusion 
(solid circles, n = 8). Changes in pre-synaptic volley amplitudes are also shown (open 
circles). b Sample waveforms of a composite field epsp and its corresponding isolated 
NMDA receptor-mediated component taken before and after glutamate application. 
Calibrations: 1mV, 10ms. 
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Figure 3 
Intracellular recording of epsps and spike probability 
A) Panel (a) illustrates recordings from a pyramidal neurone under control conditions. 
The stimulus used here to activate the Schaffer collateral and commissural axons was 
80μA, which gave approximately 50% probability of epsp-induced spike firing (7 
successes, 7 failures).  Fifty minutes after the application of glutamate, the same 
stimulus failed to evoke any spikes, and increasing the stimulation to 85μA also failed to 
do so (panel b).  In panel (c) the stimulation was increased further to 90μA, when a 
probability of approximately 50% was restored (6 successes, 8 failures).  
B) summarises all the intracellular data, plotting the probability of spike firing at different 
stimulus intensities. Data are shown as mean ± s.e.m (n = 11 neurons). At several 
stimulus intensities there was a highly significant difference between the experimental 
points.  
Calibrations: 10mV and 10ms. The amplitudes of the spikes are restricted by the 
recording bandwidth. 
***P < 0.001 between baseline and post-glutamate probabilities 
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Figure 4 
Modulation by adenosine A1 receptor blockade of the effects of glutamate 
A) Bar chart summarising the % orthodromic spike recovery following 5mM glutamate 
with or without DPCPX. There is a significant difference between the recovery of 
potentials affected by glutamate (n = 9) and those recorded after glutamate + DPCPX (n 
= 11; * P < 0.01 Bonferroni Multiple Comparisons test against 5mM glutamate control).  
B) Sample waveforms of orthodromic population spikes before and after glutamate 
alone or DPCPX + glutamate. Calibrations: 1mV, 5ms. 
C) Bar chart summarising the % antidromic spike recovery following 5mM glutamate (n 
= 4) or 30nM DPCPX + 5mM glutamate (n = 4).  
D) Bar chart summarising the % field epsp slope and amplitude recovery following 5mM 
glutamate (n = 8) or 30nM DPCPX + 5mM glutamate (n = 12).  
E) Bar chart summarising the % NMDA receptor-mediated epsp slope and amplitude 
recovery following 5mM glutamate with or without DPCPX. There is a significant 
difference between NMDA receptor-mediated epsp amplitudes affected by glutamate (n 
= 7) and those obtained after perfusion by glutamate + DPCPX (n = 6)(*P = 0.045, 
unpaired t test). However, there was no significant difference between the epsp slopes 
for each treatment group (P = 0.12).   
F) Sample waveforms of isolated NMDA receptor-mediated epsps before and after 
glutamate alone or DPCPX + glutamate. Calibrations: 1mV, 10ms. 
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Figure 5 
Intracellular recording of epsps and spike probability 
A) Panel (a) illustrates recordings from a pyramidal neurone under control conditions. 
The stimulus used here to activate the Schaffer collateral and commissural axons was 
80μA, which gave approximately 50% probability of epsp-induced spike firing (11 
successes, 13 failures).  Fifty minutes after the application of glutamate but in the 
presence of the adenosine A1 receptor blocker DPCPX, the same stimulus still evoked 
epsps which triggered spikes with a high probability (7 successes, 14 failures). 
compared with the greatly reduced probability noted after glutamate alone.  
B) summarises the intracellular data, plotting the probability of spike firing at different 
stimulus intensities. Data are shown as mean ± s.e.m (n = 8 neurons). At only one 
stimulus intensity was there a just significant difference between the mean probabilities. 
Calibrations: 10mV and 10ms. The amplitudes of the spikes are restricted by the 
recording bandwidth. 
*P < 0.05 between baseline and post-glutamate probabilities. 
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